- Home
- TARA vs FDBC Comparison
TARA vs FDBC Comparison
Compare TARA & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARA | FDBC |
|---|---|---|
| Founded | N/A | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.5M | 253.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TARA | FDBC |
|---|---|---|
| Price | $7.26 | $42.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 7.6K |
| Earning Date | 03-04-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 4.03% |
| EPS Growth | N/A | ★ 35.81 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $91,960,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.74 |
| Revenue Growth | N/A | ★ 15.78 |
| 52 Week Low | $2.77 | $37.00 |
| 52 Week High | $7.82 | $50.00 |
Technical Indicators
Market Signals| Indicator | TARA | FDBC |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 41.48 |
| Support Level | $4.72 | $43.23 |
| Resistance Level | $7.42 | $44.12 |
| Average True Range (ATR) | 0.45 | 1.10 |
| MACD | 0.23 | -0.00 |
| Stochastic Oscillator | 89.33 | 12.59 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.